Take a look at the beta version of dw.com. We're not done yet! Your opinion can help us make it better.
Word has spread of a therapy — only found in Germany — that can help with long COVID. What is it? And does it really work?
Karl Lauterbach has recommended the voluntary wearing of masks indoors and indicated that stricter rules could be on their way. Those hit early in the Omicron wave may be vulnerable to reinfection.
Every year in Germany, 500,000 people are diagnosed with cancer. Only about half of these people can be cured. It’s no wonder that the pharmaceutical industry works tirelessly to deliver improved treatments.
For patients with long COVID, understanding the symptoms or even getting recognition for the disease has been hard. DW spoke with one expert who answered a few of our most pressing questions.
US President Joe Biden has unveiled his plan for fighting the pandemic this winter. Meanwhile, GlaxoSmithKline has said its COVID-19 therapy appeared to work against the new omicron variant. Follow DW for the latest.
© 2022 Deutsche Welle |
Accessibility Statement |
Legal notice |
| Mobile version